Quanta Therapeutics
PrivateLast Round
Series D
Jun 24, 2026
Total Funding Raised
$174.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Quanta Therapeutics is a biotechnology company that develops oral small molecule therapeutics for RAS-driven cancers using a proprietary Second Harmonic Generation optical platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quanta Therapeutics Comparables
Compare Quanta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kumquat Biosciences | 85% | |
| BridgeBio Pharma, Inc. | 85% | |
| Kestrel Therapeutics | 85% |
Quanta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 24, 2026 | ||||
| Series D | May 22, 2023 | ||||
| Series C | Oct 26, 2021 | ||||
| Series A | Sep 5, 2018 |
Key People
Founding team and executive leadership
Quanta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series D, Series C |
| Surveyor Capital | Series D, Series C |
| Avidity Partners Management | Series D |
| Vida Ventures | Series D, Series B, Series C |
| Avidity Partners | Series D |
| WS Investment Company | Series D |
| Logos Capital | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 72% MoM.
- Jun 24, 2026
$76M round completed.
Quanta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Quanta Therapeutics's valuation, stock price, and market status.
Is Quanta Therapeutics a public or private company?
Quanta Therapeutics is a private company.
What is the current stock price of Quanta Therapeutics?
Quanta Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Quanta Therapeutics worth (valuation)?
Valuation information for Quanta Therapeutics is not publicly available.
Can I buy Quanta Therapeutics stock?
Quanta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Quanta Therapeutics's last funding round?
Quanta Therapeutics's most recent funding round was Series B on June 24, 2026.
Who are the main investors in Quanta Therapeutics?
Key investors in Quanta Therapeutics include Avidity Partners Management, Vida Ventures, Avidity Partners, Citadel, Sofinnova Investments.
Will Quanta Therapeutics IPO soon?
No public IPO plans have been announced for Quanta Therapeutics.
How can I track Quanta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Quanta Therapeutics's secondary market activity and sign up for updates.